99 related articles for article (PubMed ID: 12508551)
1. [Significance of detecting serum tumor supplied group of factors in differential diagnosis of neck masses].
Kuang GQ; Yang RN; Mo LG
Ai Zheng; 2002 Sep; 21(9):1002-4. PubMed ID: 12508551
[TBL] [Abstract][Full Text] [Related]
2. [Detection of serum tumor supplied group of factors and its clinical significance].
Liang YR; Wan DS; Chen G; Lu ZH; Li YJ; Lin YH; Chi PD
Ai Zheng; 2002 Nov; 21(11):1251-3. PubMed ID: 12526228
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of assaying tumor supplied group of factor/tumor specific growth factor in patients with solitary pulmonary nodule.
Deng B; Tan QY; Fan XQ; Jiang YG; Zhao YP; Zhou JH; Liang YG; Wang RW
Clin Lung Cancer; 2011 May; 12(3):192-6. PubMed ID: 21663863
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].
Li YP; Hu CP; Yang HZ
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):608-10. PubMed ID: 15804072
[TBL] [Abstract][Full Text] [Related]
5. Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis.
Milojkovic M; Hrgovic Z; Hrgovic I; Jonat W; Maass N; Buković D
Arch Gynecol Obstet; 2004 Mar; 269(3):176-80. PubMed ID: 14557888
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of tumor-associated growth factor detection in the diagnosis of colorectal carcinoma].
Yang J; Wang D
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1577-9. PubMed ID: 17959542
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of combined detection of CYFRA21-1 and TSGF in nasopharyngeal carcinoma].
Huang L; Huang W; Chen Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(5):201-2. PubMed ID: 15934283
[TBL] [Abstract][Full Text] [Related]
8. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
[TBL] [Abstract][Full Text] [Related]
9. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
Pauli C; Stieber P; Schmitt UM; Andratschke M; Hoffmann K; Wollenberg B
Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
[TBL] [Abstract][Full Text] [Related]
11. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
[TBL] [Abstract][Full Text] [Related]
12. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.
Coskun U; Bukan N; Sancak B; Günel N; Ozenirler S; Unal A; Yucel A
Neoplasma; 2004; 51(3):209-13. PubMed ID: 15254675
[TBL] [Abstract][Full Text] [Related]
13. Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group.
Shimada H; Ochiai T; Nomura F;
Cancer; 2003 Feb; 97(3):682-9. PubMed ID: 12548611
[TBL] [Abstract][Full Text] [Related]
14. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].
Feng C; Li HZ; Yan WG; Gao JG; Xu WF; Luo YF; Cao JL
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1697-700. PubMed ID: 18476530
[TBL] [Abstract][Full Text] [Related]
15. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
17. Elevated tumor marker CA 19-9 in the differential diagnosis of pancreatic mass lesions.
Cwik G; Wallner G; Skoczylas T; Krzyzanowski M; Ciechainski A; Madro P
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):213-8. PubMed ID: 16146081
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic efficiency of serum lipid-bound sialic acid level in malignant pleural effusions].
Bektemür G; Ozer F; Kanat F; Imecik O
Tuberk Toraks; 2003; 51(3):265-70. PubMed ID: 15143404
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of new serum tumor markers in head and neck squamous cell carcinoma.
Marcos CA; Martínez DA; de Los Toyos JR; Domínguez Iglesias F; Hermsen M; Guervós MA; Pendás JL
Otolaryngol Head Neck Surg; 2009 Mar; 140(3):375-80. PubMed ID: 19248946
[TBL] [Abstract][Full Text] [Related]
20. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]